#GCOS25 Session 1: Cardio-Oncology in Africa. Very interesting basic science done in Africa focusing on: - Inflammation and thrombotic risk. - Targeting HDL particles. - The role of traditional African plants. #GCOS25 #GCOS2025 #CardioOnc International Cardio-Oncology Society OncoDaily

#GCOS25 Session 2: Novel insights in Cardio-Oncology. - Treating cancer with a heartbeat - Update on ferroptosis in cardio-oncology - Disruption of endothelial cells dynamic with cancer #GCOS25 #GCOS2025 #CardioOnc International Cardio-Oncology Society OncoDaily

GCOS 2025 🇿🇦 is off to a great start with the Research and Basic Science workshop! Don’t miss out - share your favorite moments with #GCOS25. #cardioonc #cardiooncology #GCOS

#GCOS25 starts NOW! Join us for our welcome session with Alexander Lyon (UK 🇬🇧), Trishun Singh (RSA 🇿🇦) and Susan Dent, MD FRCPC Dent (USA 🇺🇸 - Susan dent ) #cardioonc #cardiooncology

Christine Brezden presenting an oncologists perspective as to when to call the cardiooncologist? Practical guidance for all of us to follow! #cardioonc International Cardio-Oncology Society Maria Sol Andres MD, MSc 🇦🇷🇬🇧 Susan dent

When should I call #CardioOncology? Think early, not late. Beautiful start at #GCOS25 by Dr Christine Brezden 📍Modern cancer therapies are improving survival, but cardiovascular effects can emerge early and late 📍Partnering with #CardioOnc improves oncologic outcomes by enabling

The incredible ⁦Sohaib Nazir⁩ discussing lipids and cancer. #GCOS25 #cardiooncology #lipids #oncology

Mike Fradley, MD providing an overview of the #cardioonc guidelines. Have a look at te second picture for a sound summary of this enlightening lecture. #GCOS2025 International Cardio-Oncology Society Susan dent

Joint session International Cardio-Oncology Society × #ESCardioOnco at #GCOS25 🫀 Mike Fradley, MD delivered a practical breakdown of the European Society of Cardiology #CardioOncology guidelines: 📍Prioritize Class I (do) vs Class III (don’t) 📍Baseline CV risk assessment for all patients 📍“Permissive cardiotoxicity” when

Dr Greg Armstrong talking about CV risks in paedriatic cancer survivors #GCOS25 🔸Healthy lifestyle ⬇️excess deaths 🔸Intermediate CV events ⬆️risk of MACE in cancer survivors 🔸Abnormal GLS + abnormal NTproBNP ⬆️ x4 risk of future cardiomyopathy #CardioOnc International Cardio-Oncology Society

Who needs Surveillance, When and How? Dr Anju Nohria #GCOS25 🔸Early detection of cardiotoxicity prevents irreversible damage 🔸Screening: guided by type of therapy and baseline risk 🔸Individualised life long CV monitoring for high-risk cancer survivors. #CardioOnc International Cardio-Oncology Society

Great talk by Sohaib Nazir about Lipid management and Vascular Health in Cancer Survivors #GCOS25 🔸CV disease is the leading cause of late mortality 🔸Risk score tools underestimate risk in cancer patients 🔸Conventional lipid lowering therapies are safe #CardioOnc International Cardio-Oncology Society

How to successfully implement #ESCguidelines on #CardioOncology in clinical practice? Key points from Dr #AlexLyon at the @icosociety × #ESCardioOnco #GCOS25 joint session: 📍perform baseline CV risk assessment (use the app‼️) 📍Refer high-risk patients to 🫀 📍Tailor

A milestone at #GCOS2025 ✨the first International Cardio-Oncology Society × European Society of Cardiology #ESCardioOnco joint session Today’s discussion brought together global expertise to move from guidelines to real-world practice, address challenges across diverse settings, & ensure patients benefit from evidence-based

Day 3 of #gcos2025 starting now! Congrats Teresa Lopez Fernandez winner of the 2025 Thomas Force Award. Your dedication and impact to #cardioonc are truly profound! Thank you for everything International Cardio-Oncology Society Susan dent European Society of Cardiology

Congrats to the 2025 Thomas Force Pioneer Award Winner 🏆 - Teresa López Fernández ( Teresa Lopez Fernandez ) ! Teresa has contributed singificantly to the #cardiooncology field both in her capacity at IC-OS and beyond. Meet Teresa: tinyurl.com/22aayh99

Congralutations Dr Teresa Lopez Fernandez for winning the 2025 Thomas Force award 🎊 #GCOS25 In her lecture this morning she reviewed the important role of multimodality imaging in cardio-oncology with a focus on how to target imaging in a pragmatic way. #CardioOnc International Cardio-Oncology Society

Dr. Sebastian Szmit’s excellent talk on Venous Thromboembolism (VTE) in cancer patients. 🩸🎗️ When lifelong or extended anticoagulation is needed, what’s the best approach? The API-CAT trial shows that reduced-dose Apixaban is non-inferior to full dose for preventing recurrent

How Do I Manage High BP? with Dr Ninian Lang #GCOS25 🔸Baseline BP>140/90mmHg ➡️x2 risk of HF. 🔸Intensive BP control is safe in cancer patients. 🔸Treatment: 1) ACEI/ARB 2) MRA, nitrates, Hydralazine, BB 3) Thiazides and a-block **Avoid: verapamil, diltiazem International Cardio-Oncology Society

How Do I Manage QTc Prolontation? Dr Chris Plummer #GCOS25 🔸Use Fridericia formula 🔸Normal values: 👨🏻350-450ms, 👩🏻360-460ms 🔸QTc > 500ms or an increase of >60ms from baseline ⬆️ risk of TdP. 🔸Baseline QTc should be measured before cancer treatment. #CardioOnc International Cardio-Oncology Society